First Allied Advisory Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.28M Sell
4,497
-757
-14% -$211K 0.04% 408
2020
Q2
$1.41M Sell
5,254
-393
-7% -$118K 0.05% 358
2020
Q1
$1.79M Sell
5,647
-315
-5% -$95.6K 0.08% 265
2019
Q4
$1.76M Sell
5,962
-2,751
-32% -$763K 0.06% 337
2019
Q3
$2.02M Sell
8,713
-1,320
-13% -$307K 0.07% 299
2019
Q2
$2.35M Sell
10,033
-625
-6% -$144K 0.08% 272
2019
Q1
$2.5M Buy
10,658
+119
+1% +$37.5K 0.09% 252
2018
Q4
$3.21M Sell
10,539
-711
-6% -$227K 0.13% 193
2018
Q3
$3.96M Buy
11,250
+519
+5% +$179K 0.14% 176
2018
Q2
$3.11M Sell
10,731
-608
-5% -$171K 0.12% 202
2018
Q1
$3.1M Buy
11,339
+1,955
+21% +$607K 0.12% 195
2017
Q4
$3.01M Buy
9,384
+302
+3% +$96.9K 0.12% 191
2017
Q3
$2.86M Sell
9,082
-437
-5% -$129K 0.12% 187
2017
Q2
$2.59M Buy
9,519
+283
+3% +$74.8K 0.12% 202
2017
Q1
$2.55M Buy
9,236
+1,216
+15% +$344K 0.13% 176
2016
Q4
$2.27M Sell
8,020
-335
-4% -$99.3K 0.11% 204
2016
Q3
$2.62M Sell
8,355
-880
-10% -$261K 0.14% 175
2016
Q2
$2.22M Buy
9,235
+712
+8% +$188K 0.12% 188
2016
Q1
$2.22M Buy
8,523
+1,014
+14% +$268K 0.12% 187
2015
Q4
$2.31M Buy
7,509
+1,707
+29% +$491K 0.12% 191
2015
Q3
$1.7M Buy
5,802
+2,084
+56% +$688K 0.09% 250
2015
Q2
$1.49M Buy
3,718
+550
+17% +$221K 0.07% 318
2015
Q1
$1.34M Buy
3,168
+664
+27% +$262K 0.09% 266
2014
Q4
$841K Buy
2,504
+1,148
+85% +$371K 0.06% 372
2014
Q3
$452K Buy
1,356
+197
+17% +$65K 0.04% 545
2014
Q2
$364K Buy
1,159
+146
+14% +$43.9K 0.03% 637
2014
Q1
$308K Buy
1,013
+55
+6% +$17.5K 0.02% 709
2013
Q4
$274K Buy
958
+39
+4% +$10.1K 0.02% 701
2013
Q3
$209K Buy
+919
New +$206K 0.01% 867

Other funds holding BIIB